Corcept Therapeutics (NASDAQ: CORT) STOCK RECOMMENDATION
Idea | BUY |
Buy Range | 45.5 – 46.5 |
Target | 49.5 – 50 |
StopLoss* | below 43.75 |
Duration | 12-14 Trading Days |
Potential Returns | 6% – 8% |
Idea | Buy Range | Target | StopLoss* | Duration | Potential Returns |
BUY | 45.5 – 46.5 | 49.5 – 50 | below 43.75 | 12-14 Trading Days | 6% – 8% |
* Once the first target hit, reset the StopLoss at your buying price.
Our recommendations are authentic and transparent. Find this recommendation posted in Tradingview. Be assured such records are permanent and irreversible.
Corcept Therapeutics (NASDAQ: CORT) STOCK OVERVIEW
Corcept Therapeutics is a biopharmaceutical company dedicated to developing innovative treatments for severe endocrine, oncologic, and metabolic disorders. Their lead product, Korlym, is approved for Cushing’s syndrome, a rare endocrine condition. Corcept is also advancing several pipeline candidates, including relacorilant for Cushing’s syndrome, treatments for various cancers, and potential therapies for neurological conditions like amyotrophic lateral sclerosis and nonalcoholic steatohepatitis. Founded in 1998, Corcept is based in Menlo Park, California.
Stock Data | |
NASDAQ Symbol | CORT |
Sectoral Index | Biotechnology |
52 Weeks High | 47.71 |
52 Weeks Low | 20.84 |
Corcept Therapeutics (NASDAQ: CORT) - RELATIVE STRENGTH

Relative Performance - Last 1 Year
CORT — NASDAQ —
Corcept Therapeutics (NASDAQ: CORT) - DAILY TECHNICAL ANALYSIS

- After an extended period of consolidation, the stock price has formed an Inverted Head & Shoulders pattern.
- After breaking out, the stock has settled above the breakout level and then jumped higher.
- A bullish Pole & Flag pattern is now visible on the chart, and with the recent breakout, the stock price is aiming for new highs.
Corcept Therapeutics (NASDAQ: CORT) - RSI

- Current RSI of this stock is 69.31, which indicates the strength of buyers.
Corcept Therapeutics (NASDAQ: CORT) - ADX & DI

- Increasing ADX value above 20, indicated the strength of the trend, thereby uptrending ADX confirms the bullish or bearish supportive decisions. Along with the rising ADX, and the +DI is above (or crossing) -DI, indicates the long trades should be favoured.
Corcept Therapeutics (NASDAQ: CORT) - EMA Cross

- The short length exponential moving average (10 EMA) has crossed the long length exponential moving average (20 EMA) from the below, generates bullish signal. Last dayโs candle has closed above all these moving averages. This suggests buyers are taking interest in this stock.
CONCLUSION - Corcept Therapeutics (NASDAQ: CORT) STOCK PRICE FORECAST
Based on our stock trading advice in USA, Corcept Therapeutics stock price target will be USD 49.5 – USD 50 in the next 12-14 trading sessions.